Pudumjee Paper Products' standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations grew 3.3% YoY to ₹202.9 Cr, but net profit fell 6.9% YoY to ₹33.7 Cr from ₹36.2 Cr, even as operating margin (OPM) expanded to 17.5% from 17.1% a year earlier — the core paper and hygiene businesses turned in a marginally better underlying quarter even as the headline bottom line contracted.
The YoY profit decline was not driven by the operating business: EBITDA excluding other income rose to ₹35.6 Cr from ₹33.7 Cr YoY. Instead, three below-the-line items pulled PBT down 7.5% YoY to ₹44.7 Cr — other income fell 16% YoY to ₹15.6 Cr (from ₹18.6 Cr), finance cost more than doubled to ₹1.56 Cr from ₹0.64 Cr, and depreciation rose 48.8% to ₹4.94 Cr from ₹3.32 Cr, consistent with ongoing capacity-related capex. By segment, the core Paper business (₹195.1 Cr revenue, ₹37.5 Cr segment EBITDA) carried the quarter, while the smaller Hygiene Products segment's EBITDA fell to ₹0.27 Cr from ₹0.72 Cr YoY despite 17% revenue growth to ₹16.2 Cr, pointing to margin pressure in that unit.
QoQ, PAT jumped 71% from ₹19.7 Cr in Q4 FY26, but that comparison is misleading: Q4 FY26 carried a rare ₹0.74 Cr negative other-income swing that depressed the base quarter's profit, so the sequential jump is largely a base-effect normalization rather than a genuine step-up in earnings power — the YoY read, where profit growth trailed revenue growth, is the one that matters here.
There is no management guidance or prior concall commentary in our records to grade this print against, and no analyst consensus estimate for this specific quarter's revenue or PAT could be verified — only a general analyst note (Univest, May 2026) flagging Q1 FY27 as a checkpoint quarter for its ₹280 base-case target, without number estimates, so vsStreet is marked unknown. No separate management press release accompanied the exchange filing beyond the board-outcome letter. Separately, the company had already announced a ₹0.60/share dividend with an August 24, 2026 record date, disclosed ahead of this result and unrelated to this quarter's earnings trajectory.